Concepedia

Publication | Closed Access

64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

275

Citations

15

References

2001

Year

Carolyn J. Anderson, Farrokh Dehdashti, Paul Cutler, Sally W. Schwarz, Richard Laforest, Laura A. Bass, Jason S. Lewis, D. W. Mccarthy
PubMed

Abstract

The high rate of lesion detection, sensitivity, and favorable dosimetry and pharmacokinetics of 64Cu-TETA-OC indicate that it is a promising radiopharmaceutical for PET imaging of patients with neuroendocrine tumors.

References

YearCitations

Page 1